Is losartan a calcium channel blocker
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Is Losartan a Calcium Channel Blocker?
Introduction to Losartan and Calcium Channel Blockers
Losartan is a medication commonly used to treat high blood pressure and to protect the kidneys from damage due to diabetes. It belongs to a class of drugs known as angiotensin II receptor blockers (ARBs). Calcium channel blockers (CCBs), on the other hand, are another class of medications used to manage hypertension and other cardiovascular conditions by inhibiting the entry of calcium ions into cardiac and smooth muscle cells, which helps to relax and widen blood vessels.
Losartan's Classification and Mechanism of Action
Losartan is not a calcium channel blocker. It is an angiotensin II receptor blocker (ARB). ARBs work by blocking the action of angiotensin II, a chemical in the body that narrows blood vessels and releases hormones that can raise blood pressure. By blocking this action, losartan helps to relax blood vessels, thereby lowering blood pressure and improving blood flow .
Combination Therapies Involving Losartan and Calcium Channel Blockers
While losartan itself is not a calcium channel blocker, it is often used in combination with calcium channel blockers to enhance the antihypertensive effects. Studies have shown that combining losartan with amlodipine, a calcium channel blocker, can provide a synergistic effect in lowering blood pressure more effectively than when losartan is combined with diuretics. This combination therapy has been found to improve both office and 24-hour ambulatory blood pressure measurements significantly.
Pharmacokinetic Interactions Between Losartan and Calcium Channel Blockers
Research has also explored the pharmacokinetic interactions between losartan and calcium channel blockers like amlodipine. These studies indicate that while amlodipine can affect the pharmacokinetics of losartan, the combination is generally well-tolerated and does not cause substantial pharmacokinetic interactions. This makes the combination a viable option for patients requiring dual therapy for hypertension .
Comparative Efficacy in Hypertensive Patients
Comparative studies have demonstrated that the combination of losartan and calcium channel blockers is as effective as other combinations, such as losartan with hydrochlorothiazide, in improving left ventricular relaxation in hypertensive patients. Additionally, losartan combined with amlodipine has shown favorable outcomes in reducing proteinuria in patients with chronic kidney disease, which is an added benefit beyond blood pressure control .
Conclusion
In summary, losartan is not a calcium channel blocker; it is an angiotensin II receptor blocker. However, it is often used in combination with calcium channel blockers like amlodipine to achieve better blood pressure control and additional therapeutic benefits. This combination has been shown to be effective and well-tolerated in various clinical settings, making it a valuable option in the management of hypertension and related conditions.
Sources and full results
Most relevant research papers on this topic